Literature DB >> 17374640

Intracellular pathway of Onconase that enables its delivery to the cytosol.

Montserrat Rodríguez1, Gerard Torrent, Montserrat Bosch, Fabienne Rayne, Jean-François Dubremetz, Marc Ribó, Antoni Benito, Maria Vilanova, Bruno Beaumelle.   

Abstract

Onconase is an RNase with a very specific property because it is selectively toxic to transformed cells. This toxin is thought to recognize cell surface receptors, and the protection conferred by metabolic poisons against Onconase toxicity indicated that this RNase relies on endocytic uptake to kill cells. Nevertheless, its internalization pathway has yet to be unraveled. We show here that Onconase enters cells using AP-2/clathrin-mediated endocytosis. It is then routed, together with transferrin, to the receptor recycling compartment. Increasing the Onconase concentration in this structure using tetanus toxin light chain expression enhanced Onconase toxicity, indicating that recycling endosomes are a key compartment for Onconase cytosolic delivery. This intracellular destination is specific to Onconase because other (and much less toxic) RNases follow the default pathway to late endosomes/lysosomes. Drugs neutralizing endosomal pH increased Onconase translocation efficiency from purified endosomes during cell-free translocation assays by preventing Onconase dissociation from its receptor at endosomal pH. Consistently, endosome neutralization enhanced Onconase toxicity up to 100-fold. Onconase translocation also required cytosolic ATP hydrolysis. This toxin therefore shows an unusual entry process that relies on clathrin-dependent endocytic uptake and then neutralization of low endosomal pH for efficient translocation from the endosomal lumen to the cytosol.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374640     DOI: 10.1242/jcs.03427

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  21 in total

Review 1.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

2.  Cytostatic and cytotoxic properties of Amphinase: a novel cytotoxic ribonuclease from Rana pipiens oocytes.

Authors:  Barbara Ardelt; Wojciech Ardelt; Piotr Pozarowski; Jan Kunicki; Kuslima Shogen; Zbigniew Darzynkiewicz
Journal:  Cell Cycle       Date:  2007-09-12       Impact factor: 4.534

3.  Mechanism of ribonuclease A endocytosis: analogies to cell-penetrating peptides.

Authors:  Tzu-Yuan Chao; Ronald T Raines
Journal:  Biochemistry       Date:  2011-09-07       Impact factor: 3.162

Review 4.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 5.  Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

Authors:  W Ardelt; K Shogen; Z Darzynkiewicz
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

6.  Fluorogenic label to quantify the cytosolic delivery of macromolecules.

Authors:  Tzu-Yuan Chao; Ronald T Raines
Journal:  Mol Biosyst       Date:  2013-01-22

Review 7.  Ribonucleases as novel chemotherapeutics : the ranpirnase example.

Authors:  J Eugene Lee; Ronald T Raines
Journal:  BioDrugs       Date:  2008       Impact factor: 5.807

Review 8.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

9.  Mechanism for HIV-1 Tat insertion into the endosome membrane.

Authors:  Hocine Yezid; Karidia Konate; Solène Debaisieux; Anne Bonhoure; Bruno Beaumelle
Journal:  J Biol Chem       Date:  2009-06-23       Impact factor: 5.157

10.  TNF-alpha mediates eosinophil cationic protein-induced apoptosis in BEAS-2B cells.

Authors:  Kun-Che Chang; Chih-Wei Lo; Tan-Chi Fan; Margaret Dah-Tsyr Chang; Chih-Wen Shu; Chuan-Hsin Chang; Cheng-Ta Chung; Shun-Lung Fang; Chih-Chung Chao; Jaw-Ji Tsai; Yiu-Kay Lai
Journal:  BMC Cell Biol       Date:  2010-01-20       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.